Maria V. Avksentieva
Research Subjects
Maria V. Avksentieva has a total of 101 co-authors. Here are the top co-authors by number of shared publications:
- Inna Alexandrovna Zheleznyakova
Center for Expertise and Quality Control of Medical Care
7 shared publications - Vitaliy Vladimirovich Omelyanovskiy
Center for Healthcare Quality Assessment and Control; Russian Medical Academy of Continuing Professional Education
7 shared publications - E. I. Rumiantseva
Center for Expertise and Quality Control of Medical Care
6 shared publications - A. V. Zuev
Center for Expertise and Quality Control of Medical Care
5 shared publications - D. V. Fedyaev
Center for Healthcare Quality Assessment and Control; Russian Medical Academy of Continuing Professional Education; Financial Research Institute
5 shared publications - O. S. Plakhotnik
Center for Expertise and Quality Control of Medical Care
5 shared publications
Latest Publications
- 26 June 2026
- Published by Media Sphere Publishing Group in Medical Technologies. Assessment and Choice
- Vol. 48 (2)
Main changes in diagnosis-related group payment model in the Russian Federation in 2026
The content and/or weight coefficients of Russian diagnosis-related groups (DRG) for inpatient and day care payment have been updated for 2026. Following clinical guidelines, changes were made in DRG for payment of therapy for malignant neoplasms in adults, intestinal infections and infections caused by polyresistant microflora. Six new groups were formed to pay for preimplantation genetic testing in fertilization in vitro (IVF). Weight coefficients of DRG for the treatment of chronic viral hepatitis B and C, for using genetically engineered biological agents and selective immunosuppressants, as well as IVF were recalculated. Three new groups were formed in medical rehabilitation profile. Accounting for the dose of normal human immunoglobulin in the treatment of complex neurological diseases was introduced.
- 26 June 2026
- Published by Media Sphere Publishing Group in Medical Technologies. Assessment and Choice
- Vol. 48 (2)
Main changes in diagnosis-related group payment model in the Russian Federation in 2026
The content and/or weight coefficients of Russian diagnosis-related groups (DRG) for inpatient and day care payment have been updated for 2026. Following clinical guidelines, changes were made in DRG for payment of therapy for malignant neoplasms in adults, intestinal infections and infections caused by polyresistant microflora. Six new groups were formed to pay for preimplantation genetic testing in fertilization in vitro (IVF). Weight coefficients of DRG for the treatment of chronic viral hepatitis B and C, for using genetically engineered biological agents and selective immunosuppressants, as well as IVF were recalculated. Three new groups were formed in medical rehabilitation profile. Accounting for the dose of normal human immunoglobulin in the treatment of complex neurological diseases was introduced.
- 17 March 2026
- Published by Media Sphere Publishing Group in Medical Technologies. Assessment and Choice
- Vol. 48 (1) , 78-91
Direct and indirect costs associated with state of health in patients receiving home-based respiratory support and oxygen therapy
Objective. To assess direct and indirect costs caused by state of health of patients suffering from chronic respiratory failure (CRF) and receiving respiratory support and oxygen therapy (RSOT) at home but not directly related to participation of patients in the study (i.e., with provision of RSOT). Material and methods. We analyzed direct medical, direct non-medical and indirect costs caused by state of health of patients suffering from CRF and receiving RSOT at home, but not directly related to participation of patients in the study (i.e., with provision of RSOT). We extracted data from patients’ diaries and individual registration cards. In accordance with study protocol, these diaries and cards contained information about medical and social assistance, purchase of medical devices, temporary disability with indication of funding source (compulsory medical insurance system (CMI) or personal funds of patients and their families). Costs of medical care at the expense of CMI were based on tariffs and standards of financial expenses in Moscow. Costs incurred from personal funds were received from diaries. Direct non-medical costs included transportation costs, professional care at home, and payments related to temporary disability. Indirect costs were estimated as losses of gross domestic product (GDP) due to temporary disability of patients of working age. Cost data was collected and processed in subgroup of 65 patients (66.3% of 98 participating in the study). Total costs and weighted average costs per a patient were determined for study period (8.7 months) and calculated on annual basis. Results. Total costs for the entire subgroup throughout study period amounted to RUB 42.6 million, including RUR 6.4 million (14.9%) of direct medical costs, RUB 9.8 million (23.0%) of direct non–medical costs and RUB 26.5 million (62.1%) of indirect costs as GDP losses. Maximum share accounted to inpatient medical care in the structure of direct medical costs. About 9% of direct medical expenses and 38% of direct non-medical expenses were paid from personal funds. Weighted mean cost per a patient per year was as follows: direct medical costs — RUB 34.2 thousand; direct non–medical costs — RUB 200.9 thousand, indirect costs — RUB 642.9 thousand. Conclusion. Health status in patients with chronic respiratory failure receiving respiratory support and oxygen therapy at home represents a significant economic burden for society and state, primarily due to indirect costs associated with disability of working-age patients. These data may be used to analyze budgetary impact of medical interventions in this patient group.
- 17 March 2026
- Published by Media Sphere Publishing Group in Medical Technologies. Assessment and Choice
- Vol. 48 (1) , 78-91
Direct and indirect costs associated with state of health in patients receiving home-based respiratory support and oxygen therapy
Objective. To assess direct and indirect costs caused by state of health of patients suffering from chronic respiratory failure (CRF) and receiving respiratory support and oxygen therapy (RSOT) at home but not directly related to participation of patients in the study (i.e., with provision of RSOT). Material and methods. We analyzed direct medical, direct non-medical and indirect costs caused by state of health of patients suffering from CRF and receiving RSOT at home, but not directly related to participation of patients in the study (i.e., with provision of RSOT). We extracted data from patients’ diaries and individual registration cards. In accordance with study protocol, these diaries and cards contained information about medical and social assistance, purchase of medical devices, temporary disability with indication of funding source (compulsory medical insurance system (CMI) or personal funds of patients and their families). Costs of medical care at the expense of CMI were based on tariffs and standards of financial expenses in Moscow. Costs incurred from personal funds were received from diaries. Direct non-medical costs included transportation costs, professional care at home, and payments related to temporary disability. Indirect costs were estimated as losses of gross domestic product (GDP) due to temporary disability of patients of working age. Cost data was collected and processed in subgroup of 65 patients (66.3% of 98 participating in the study). Total costs and weighted average costs per a patient were determined for study period (8.7 months) and calculated on annual basis. Results. Total costs for the entire subgroup throughout study period amounted to RUB 42.6 million, including RUR 6.4 million (14.9%) of direct medical costs, RUB 9.8 million (23.0%) of direct non–medical costs and RUB 26.5 million (62.1%) of indirect costs as GDP losses. Maximum share accounted to inpatient medical care in the structure of direct medical costs. About 9% of direct medical expenses and 38% of direct non-medical expenses were paid from personal funds. Weighted mean cost per a patient per year was as follows: direct medical costs — RUB 34.2 thousand; direct non–medical costs — RUB 200.9 thousand, indirect costs — RUB 642.9 thousand. Conclusion. Health status in patients with chronic respiratory failure receiving respiratory support and oxygen therapy at home represents a significant economic burden for society and state, primarily due to indirect costs associated with disability of working-age patients. These data may be used to analyze budgetary impact of medical interventions in this patient group.
- 9 September 2025
- Published by Media Sphere Publishing Group in Medical Technologies. Assessment and Choice
- Vol. 47 (3)
Costs of home-based respiratory support and oxygen therapy
Objective. To assess the direct costs associated with home-based respiratory support and oxygen therapy (RSOT). Material and methods. The study included two stages: prospective follow-up of patients receiving home-based RSOT and economic analysis of results. There were 98 patients (mean age 61 years, 56.9% men) divided into 3 groups depending on home-based RSOT: invasive mechanical ventilation (IMV) — 8 (8.2%), non-invasive ventilation (NIV) — 43 (43.9%) and long-term oxygen therapy (LTOT) — 47 (47.9%). Direct costs of home-based RSOT were estimated. Results. The weighted average monthly expenses per patient with chronic respiratory failure (CRF) requiring RSOT at home were RUR 115.046 (95% CI: RUR 120.374 — 109.717) for IMV, RUR 39.905 (95% CI: RUR 44.336 — RUR 35.473) for NIV and RUR 10.518 (95% CI: RUR 11.128 — RUR 9.909) for LTOT. Most of these costs were related to provision of necessary equipment. Conclusion. Direct costs for home-based RSOT decrease sequentially from IMV to NIV and LTOT.
- 9 September 2025
- Published by Media Sphere Publishing Group in Medical Technologies. Assessment and Choice
- Vol. 47 (3)
Costs of home-based respiratory support and oxygen therapy
Objective. To assess the direct costs associated with home-based respiratory support and oxygen therapy (RSOT). Material and methods. The study included two stages: prospective follow-up of patients receiving home-based RSOT and economic analysis of results. There were 98 patients (mean age 61 years, 56.9% men) divided into 3 groups depending on home-based RSOT: invasive mechanical ventilation (IMV) — 8 (8.2%), non-invasive ventilation (NIV) — 43 (43.9%) and long-term oxygen therapy (LTOT) — 47 (47.9%). Direct costs of home-based RSOT were estimated. Results. The weighted average monthly expenses per patient with chronic respiratory failure (CRF) requiring RSOT at home were RUR 115.046 (95% CI: RUR 120.374 — 109.717) for IMV, RUR 39.905 (95% CI: RUR 44.336 — RUR 35.473) for NIV and RUR 10.518 (95% CI: RUR 11.128 — RUR 9.909) for LTOT. Most of these costs were related to provision of necessary equipment. Conclusion. Direct costs for home-based RSOT decrease sequentially from IMV to NIV and LTOT.
- Open Access
- 27 July 2025
- Published by N. A. Semashko National Research Institute of Public Health in Бюллетень Национального научно-исследовательского института общественного здоровья имени Н.А.Семашко
- No. 1,p. 70-77
Осведомленность женщин о послеродовой депрессии и отношение к внедрению скрининга на нее в Российской Федерации
Цель исследования. Выявление распространенности симптомов послеродовой депрессии (ПРД), осведомленности о ПРД и оценка приемлемости скрининга на ПРД среди женщин в первый год после родов. Материалы и методы. Проведен онлайн-опрос 360 женщин в возрасте старше 18 лет, проживающих на территории России, имеющих хотя бы одного ребенка до 1 года. Анкета включала в себя вопросы об отношении к психическим и физическим симптомам, которые могут испытывать женщины с маленькими детьми, осведомленности о ПРД и отношении к скринингу на нее, а также 13 вопросов «Эдинбургской шкалы послеродовой депрессии» (ЭШПД) и 2 вопроса «Опросника здоровья пациента» (ОЗП, англ. PHQ-2), русскоязычные версии которых валидированы для скрининга на ПРД. Результаты. Осведомленность о ПРД находится на низком уровне: испытывать различные симптомы, свидетельствующие о возможном наличии ПРД, считают нормальным до 72% опрошенных. 89% женщин (320 чел.) не проходили диагностику ПРД ни во время беременности, ни после родов. Большинство опрошенных (281 чел., 78%) готовы проходить скрининг на ПРД. 45±5,2% женщин набрали 12 и более баллов по ЭШПД, что предположительно свидетельствует о ПРД, 13±4,4% набрали от 7 до 11 баллов (предпороговое состояние, или ранняя стадия развития симптомов ПРД). По опроснику ОЗП заподозрить ПРД или предпороговую стадию можно у 73±8,2% женщин. Выявлена статистически значимая связь между предположительным наличием ПРД по ЭШПД и такими характеристиками как возраст (χ² = 12.45, p = 0.004), социальный статус (χ² = 9.67, p = 0.01), материальное положение (χ² = 10.34, p = 0.008). Несмотря на то, что 88% (317 чел.) респондентов считают, что обращение за помощью при ПРД полезно, лишь 18% (65 чел.) сами обращались за консультацией. Заключение. У женщин в течение первого года после родов наблюдается высокая распространенность симптомов, предположительно свидетельствующих о ПРД. При недостаточной осведомленности о ПРД имеет место высокая готовность проходить скрининг на нее. The aim of the study was to identify the prevalence of postnatal depression (PND) symptoms, awareness of PND and assess the acceptability of PND screening among women in the first year after childbirth. Materials and methods. An online survey of 360 women over the age of 18 living in Russia with at least one child under 1 year was conducted. The questionnaire included questions about attitudes toward mental and physical symptoms that women with small children may experience, awareness of PND and attitudes toward screening for it, as well as 13 questions from the Edinburgh Postnatal Depression Scale (EPDS) and 2 questions from the Patient Health Questionnaire (PHQ-2) used for screening Results. Awareness of PND is low: experiencing various symptoms indicating the presence of PND is considered normal by 7% of respondents (it is normal to think that the family would be better off without it) to 72% (it is normal to feel tired all the time). 89% of women (320 people) were not diagnosed with PND either during pregnancy or after childbirth. Despite the fact that 88% (317 people) of respondents believe that seeking help for PND is useful, only 18% (65 people) sought advice. The majority of respondents (281 people, 78%) are ready to undergo screening for PND. 45±5.2% of women scored 12 or more points on the ESPD, which presumably indicates PRD, 13±4.4% scored from 7 to 11 points (pre-threshold state or early stage of development of PRD symptoms). According to the OZP questionnaire, PRD or the pre-threshold stage can be suspected in 73±8.2% of women. A statistically significant connection was found between the presumptive presence of PRD according to the ESPD and such characteristics as age (χ² = 12.45, p = 0.004), social status (χ² = 9.67, p = 0.01), financial situation (χ² = 10.34, p = 0.008). Conclusion. In women, during the first year after childbirth, there is a high prevalence of symptoms presumably indicating PRD. With insufficient awareness of PPD, there is a high willingness to undergo screening for it.
- 27 July 2025
- Published by N. A. Semashko National Research Institute of Public Health in Бюллетень Национального научно-исследовательского института общественного здоровья имени Н.А.Семашко
- No. 1,p. 70-77
Open AccessОсведомленность женщин о послеродовой депрессии и отношение к внедрению скрининга на нее в Российской Федерации
Цель исследования. Выявление распространенности симптомов послеродовой депрессии (ПРД), осведомленности о ПРД и оценка приемлемости скрининга на ПРД среди женщин в первый год после родов. Материалы и методы. Проведен онлайн-опрос 360 женщин в возрасте старше 18 лет, проживающих на территории России, имеющих хотя бы одного ребенка до 1 года. Анкета включала в себя вопросы об отношении к психическим и физическим симптомам, которые могут испытывать женщины с маленькими детьми, осведомленности о ПРД и отношении к скринингу на нее, а также 13 вопросов «Эдинбургской шкалы послеродовой депрессии» (ЭШПД) и 2 вопроса «Опросника здоровья пациента» (ОЗП, англ. PHQ-2), русскоязычные версии которых валидированы для скрининга на ПРД. Результаты. Осведомленность о ПРД находится на низком уровне: испытывать различные симптомы, свидетельствующие о возможном наличии ПРД, считают нормальным до 72% опрошенных. 89% женщин (320 чел.) не проходили диагностику ПРД ни во время беременности, ни после родов. Большинство опрошенных (281 чел., 78%) готовы проходить скрининг на ПРД. 45±5,2% женщин набрали 12 и более баллов по ЭШПД, что предположительно свидетельствует о ПРД, 13±4,4% набрали от 7 до 11 баллов (предпороговое состояние, или ранняя стадия развития симптомов ПРД). По опроснику ОЗП заподозрить ПРД или предпороговую стадию можно у 73±8,2% женщин. Выявлена статистически значимая связь между предположительным наличием ПРД по ЭШПД и такими характеристиками как возраст (χ² = 12.45, p = 0.004), социальный статус (χ² = 9.67, p = 0.01), материальное положение (χ² = 10.34, p = 0.008). Несмотря на то, что 88% (317 чел.) респондентов считают, что обращение за помощью при ПРД полезно, лишь 18% (65 чел.) сами обращались за консультацией. Заключение. У женщин в течение первого года после родов наблюдается высокая распространенность симптомов, предположительно свидетельствующих о ПРД. При недостаточной осведомленности о ПРД имеет место высокая готовность проходить скрининг на нее. The aim of the study was to identify the prevalence of postnatal depression (PND) symptoms, awareness of PND and assess the acceptability of PND screening among women in the first year after childbirth. Materials and methods. An online survey of 360 women over the age of 18 living in Russia with at least one child under 1 year was conducted. The questionnaire included questions about attitudes toward mental and physical symptoms that women with small children may experience, awareness of PND and attitudes toward screening for it, as well as 13 questions from the Edinburgh Postnatal Depression Scale (EPDS) and 2 questions from the Patient Health Questionnaire (PHQ-2) used for screening Results. Awareness of PND is low: experiencing various symptoms indicating the presence of PND is considered normal by 7% of respondents (it is normal to think that the family would be better off without it) to 72% (it is normal to feel tired all the time). 89% of women (320 people) were not diagnosed with PND either during pregnancy or after childbirth. Despite the fact that 88% (317 people) of respondents believe that seeking help for PND is useful, only 18% (65 people) sought advice. The majority of respondents (281 people, 78%) are ready to undergo screening for PND. 45±5.2% of women scored 12 or more points on the ESPD, which presumably indicates PRD, 13±4.4% scored from 7 to 11 points (pre-threshold state or early stage of development of PRD symptoms). According to the OZP questionnaire, PRD or the pre-threshold stage can be suspected in 73±8.2% of women. A statistically significant connection was found between the presumptive presence of PRD according to the ESPD and such characteristics as age (χ² = 12.45, p = 0.004), social status (χ² = 9.67, p = 0.01), financial situation (χ² = 10.34, p = 0.008). Conclusion. In women, during the first year after childbirth, there is a high prevalence of symptoms presumably indicating PRD. With insufficient awareness of PPD, there is a high willingness to undergo screening for it.
- 20 June 2025
- Published by Media Sphere Publishing Group in Medical Technologies. Assessment and Choice
- Vol. 47 (2)
Changes in diagnosis-related group payment model in the Russian Federation in 2025
The content and/or weight coefficients of diagnosis-related groups (DRG) for payment for inpatient and day medical care for 2025 have been updated. Following clinical guidelines, changes have been made to the DRG in payment for drug therapy for malignant neoplasms in adults and treatment of transient ischemic attacks, vascular cerebral syndromes, cerebral hemorrhage, and cerebral infarction. For cerebrovascular disorders, the actualization resulted in a significant increase in the payment tariff. Weight coefficients of DRG to pay for the treatment of chronic viral hepatitis B and C using genetically engineered biological agents and selective immunosuppressants, as well as in vitro fertilization, were recalculated. New groups were formed according to the following profiles: “medical rehabilitation,” “neurology” (three DRGs for complex neurological diseases), “ophthalmology” (intravitreal administration of drugs), and a group “daily hospitalization for diagnostic purposes” was added.
- 20 June 2025
- Published by Media Sphere Publishing Group in Medical Technologies. Assessment and Choice
- Vol. 47 (2)
Changes in diagnosis-related group payment model in the Russian Federation in 2025
The content and/or weight coefficients of diagnosis-related groups (DRG) for payment for inpatient and day medical care for 2025 have been updated. Following clinical guidelines, changes have been made to the DRG in payment for drug therapy for malignant neoplasms in adults and treatment of transient ischemic attacks, vascular cerebral syndromes, cerebral hemorrhage, and cerebral infarction. For cerebrovascular disorders, the actualization resulted in a significant increase in the payment tariff. Weight coefficients of DRG to pay for the treatment of chronic viral hepatitis B and C using genetically engineered biological agents and selective immunosuppressants, as well as in vitro fertilization, were recalculated. New groups were formed according to the following profiles: “medical rehabilitation,” “neurology” (three DRGs for complex neurological diseases), “ophthalmology” (intravitreal administration of drugs), and a group “daily hospitalization for diagnostic purposes” was added.
- 20 June 2025
- Published by Media Sphere Publishing Group in Medical Technologies. Assessment and Choice
- Vol. 47 (2)
Prevalence of postpartum depression in the Russian Federation: a systematic review and meta-analysis
Objective. To obtain a summary estimate of the prevalence of postpartum depression (PPD) in the Russian Federation using a systematic review with a meta-analysis. Material and methods. The search for studies was conducted in two Russian and five foreign electronic bibliographic databases. The systematic review included studies on women living in the Russian Federation who gave birth to a child within 12 months; it also describes a methodology for identifying PPD and quantitative indicators of the prevalence of PPD among study participants. In a meta-analysis of 51 studies including over 12.800 participants, the overall prevalence of PPD was calculated using the DerSimonian-Laird random effects model. Additionally, the PPD prevalence was calculated separately in subgroups of studies that used different diagnostic tools at different periods and with different methodological quality. Results. The overall prevalence of PPD In Russia for all included studies is 34.47% (95% CI 29.14—39.81%), and for the last 5 years, from 2020 to 2024, 43.50% (95% CI 35.5—51.5%). The meta-regression results showed a statistically significant positive association between the year of publication and the prevalence of PPD (regression coefficient +0.019, p=0.004). Results are consistent: the resulting prevalence of PPD is not critically dependent on any single study. The prevalence of PPD among women with complicated pregnancy and childbirth was slightly higher than among women without it, but there were no statistically significant differences: 48.9% (95% CI 26.5—71.4%) vs. 42.3% (95% CI 33.5—51.1%; z=0.54; p=0.59). In high-quality studies, the mean prevalence of PPD was 5.7% lower than in the others, but this difference was not statistically significant. The cumulative PPD prevalence in studies assessed by the Edinburgh PPD Scale (EPDS) with a threshold value of ≥10 points was 49.6% (95% CI 39.3- 59.7%). Conclusion. In the Russian Federation, there is a high prevalence of postpartum depression, especially in studies performed over the past 5 years, from 2020 to 2024, which supports the need to develop measures for its detection, prevention, and treatment.
- 20 June 2025
- Published by Media Sphere Publishing Group in Medical Technologies. Assessment and Choice
- Vol. 47 (2)
Prevalence of postpartum depression in the Russian Federation: a systematic review and meta-analysis
Objective. To obtain a summary estimate of the prevalence of postpartum depression (PPD) in the Russian Federation using a systematic review with a meta-analysis. Material and methods. The search for studies was conducted in two Russian and five foreign electronic bibliographic databases. The systematic review included studies on women living in the Russian Federation who gave birth to a child within 12 months; it also describes a methodology for identifying PPD and quantitative indicators of the prevalence of PPD among study participants. In a meta-analysis of 51 studies including over 12.800 participants, the overall prevalence of PPD was calculated using the DerSimonian-Laird random effects model. Additionally, the PPD prevalence was calculated separately in subgroups of studies that used different diagnostic tools at different periods and with different methodological quality. Results. The overall prevalence of PPD In Russia for all included studies is 34.47% (95% CI 29.14—39.81%), and for the last 5 years, from 2020 to 2024, 43.50% (95% CI 35.5—51.5%). The meta-regression results showed a statistically significant positive association between the year of publication and the prevalence of PPD (regression coefficient +0.019, p=0.004). Results are consistent: the resulting prevalence of PPD is not critically dependent on any single study. The prevalence of PPD among women with complicated pregnancy and childbirth was slightly higher than among women without it, but there were no statistically significant differences: 48.9% (95% CI 26.5—71.4%) vs. 42.3% (95% CI 33.5—51.1%; z=0.54; p=0.59). In high-quality studies, the mean prevalence of PPD was 5.7% lower than in the others, but this difference was not statistically significant. The cumulative PPD prevalence in studies assessed by the Edinburgh PPD Scale (EPDS) with a threshold value of ≥10 points was 49.6% (95% CI 39.3- 59.7%). Conclusion. In the Russian Federation, there is a high prevalence of postpartum depression, especially in studies performed over the past 5 years, from 2020 to 2024, which supports the need to develop measures for its detection, prevention, and treatment.
- Open Access
- 9 December 2024
- Published by Remedium, Ltd. in Meditsinskiy sovet = Medical Council
- No. 20,p. 70-81
Respiratory support and oxygen therapy at home: Clinical results of the prospective observatory study
Introduction. Respiratory diseases are number one in the structure of general morbidity of the population of the Russian Federation. The main complication of respiratory diseases is respiratory failure, which may be treated with long-term oxygen therapy (LTOT) and respiratory support (RS): non-invasive mechanical lung ventilation (NIV) and invasive mechanical lung ventilation (IV). International medical experience indicates a widespread enough implementation of respiratory support and oxygen therapy at home (RS and OT at home) for patients including whose requiring palliative medical care.Aim. The purpose of the study was to evaluate the clinical results of implementation of respiratory support and oxygen therapy at home.Materials and methods. The study included 98 patients with chronic respiratory failure (CRF). All patients used RS and OT at home according to the Study Protocol. All patients were divided into 3 groups: LTOT - 47 patients, NIV in combination or with-out LTOT - 43 patients, IV in combination or without LTOT - 8 patients. The estimated parameters of the patients' condition were measured at the initiating visit and three subsequent control sessions. The planned duration of the Study was 9 months.Results. During the Study, a statistically significant decrease in the severity of symptoms of respiratory failure was noted (CAT and mMRC scales) as well as an improvement in the quality of life and the general condition of the patient (SF-36 questionnaire and Karnovsky scale). During the study, 38 patients required hospitalization: in 8 cases hospitalization was associated with an exacerbation of CRF. The number of successful outcomes was 87 cases.Conclusion. The Study showed that RS and OT at home is an effective and safe medical technology for patients with CFR, which reduces the manifestation of symptoms, improves the quality of life, reduces the number of hospitalizations associated with exacerbation of respiratory failure, reduces mortality, and demonstrates the effectiveness of using a modern respiratory equipment at home, as well as telemedicine technologies.
- 9 December 2024
- Published by Remedium, Ltd. in Meditsinskiy sovet = Medical Council
- No. 20,p. 70-81
Open AccessRespiratory support and oxygen therapy at home: Clinical results of the prospective observatory study
Introduction. Respiratory diseases are number one in the structure of general morbidity of the population of the Russian Federation. The main complication of respiratory diseases is respiratory failure, which may be treated with long-term oxygen therapy (LTOT) and respiratory support (RS): non-invasive mechanical lung ventilation (NIV) and invasive mechanical lung ventilation (IV). International medical experience indicates a widespread enough implementation of respiratory support and oxygen therapy at home (RS and OT at home) for patients including whose requiring palliative medical care.Aim. The purpose of the study was to evaluate the clinical results of implementation of respiratory support and oxygen therapy at home.Materials and methods. The study included 98 patients with chronic respiratory failure (CRF). All patients used RS and OT at home according to the Study Protocol. All patients were divided into 3 groups: LTOT - 47 patients, NIV in combination or with-out LTOT - 43 patients, IV in combination or without LTOT - 8 patients. The estimated parameters of the patients' condition were measured at the initiating visit and three subsequent control sessions. The planned duration of the Study was 9 months.Results. During the Study, a statistically significant decrease in the severity of symptoms of respiratory failure was noted (CAT and mMRC scales) as well as an improvement in the quality of life and the general condition of the patient (SF-36 questionnaire and Karnovsky scale). During the study, 38 patients required hospitalization: in 8 cases hospitalization was associated with an exacerbation of CRF. The number of successful outcomes was 87 cases.Conclusion. The Study showed that RS and OT at home is an effective and safe medical technology for patients with CFR, which reduces the manifestation of symptoms, improves the quality of life, reduces the number of hospitalizations associated with exacerbation of respiratory failure, reduces mortality, and demonstrates the effectiveness of using a modern respiratory equipment at home, as well as telemedicine technologies.
- Open Access
- 20 September 2024
- Published by ECO-Vector LLC in Digital Diagnostics
- Vol. 5 (2) , 178-189
Identification of indicators used to assess needs for telemedicine consultations in various profiles of medical care
BACKGROUND: A unified system for assessing the results and real contributions of telemedicine consultations to improving medical care quality in the healthcare system of the Russian Federation has not yet been developed. AIM: To develop a system of indicators for differentiated assessment of the needs for telemedicine consultations in the provision of medical care. MATERIALS AND METHODS: In the first stage, reports on the results of on-site activities of national medical research centers in regions of the Russian Federation and their annual public reports (2020–2022) were analyzed to identify indicators that determine the need for telemedicine consultations. The identified indicators were clarified and validated in an open interview with the representatives of the national medical research centers. In the second stage, the value of each indicator was determined based on the expert survey: 18 experts assessed each indicator on a scale of 1–5. Then, the weight coefficient of each indicator was calculated for their subsequent use in planning the coverage of telemedicine consultations. RESULTS: Three groups of indicators that determined the need for telemedicine consultations for different medical care profiles were as follows: (1) indicators that affect the planned volumes of telemedicine consultations, (2) indicators that characterize the efficiency and effectiveness of telemedicine consultations, and (3) indicators that characterize the validity of requests for telemedicine consultations. Group 1 included indicators of lethality, disability, hospital mortality, frequency of emergency/urgent consultations, and frequency of consultations of patients requiring intensive care. Group 2 included indicators for assessing the effectiveness and efficiency of telemedicine consultations, both subjective (result satisfaction) and objective (number of positive and negative treatment and hospitalization outcomes for cases that received where telemedicine consultations). Group 3 included indicators that characterize the validity of requests for telemedicine consultations: thoroughness of a patient’s examination before a telemedicine consultation and accuracy of the diagnosis. The weight coefficients of group 1 indicators ranged from 0.05 to 1.61 and varied for different profiles. CONCLUSION: A system of indicators was proposed for the differentiated assessment of the needs for telemedicine consultations when providing medical care.
- 20 September 2024
- Published by ECO-Vector LLC in Digital Diagnostics
- Vol. 5 (2) , 178-189
Open AccessIdentification of indicators used to assess needs for telemedicine consultations in various profiles of medical care
BACKGROUND: A unified system for assessing the results and real contributions of telemedicine consultations to improving medical care quality in the healthcare system of the Russian Federation has not yet been developed. AIM: To develop a system of indicators for differentiated assessment of the needs for telemedicine consultations in the provision of medical care. MATERIALS AND METHODS: In the first stage, reports on the results of on-site activities of national medical research centers in regions of the Russian Federation and their annual public reports (2020–2022) were analyzed to identify indicators that determine the need for telemedicine consultations. The identified indicators were clarified and validated in an open interview with the representatives of the national medical research centers. In the second stage, the value of each indicator was determined based on the expert survey: 18 experts assessed each indicator on a scale of 1–5. Then, the weight coefficient of each indicator was calculated for their subsequent use in planning the coverage of telemedicine consultations. RESULTS: Three groups of indicators that determined the need for telemedicine consultations for different medical care profiles were as follows: (1) indicators that affect the planned volumes of telemedicine consultations, (2) indicators that characterize the efficiency and effectiveness of telemedicine consultations, and (3) indicators that characterize the validity of requests for telemedicine consultations. Group 1 included indicators of lethality, disability, hospital mortality, frequency of emergency/urgent consultations, and frequency of consultations of patients requiring intensive care. Group 2 included indicators for assessing the effectiveness and efficiency of telemedicine consultations, both subjective (result satisfaction) and objective (number of positive and negative treatment and hospitalization outcomes for cases that received where telemedicine consultations). Group 3 included indicators that characterize the validity of requests for telemedicine consultations: thoroughness of a patient’s examination before a telemedicine consultation and accuracy of the diagnosis. The weight coefficients of group 1 indicators ranged from 0.05 to 1.61 and varied for different profiles. CONCLUSION: A system of indicators was proposed for the differentiated assessment of the needs for telemedicine consultations when providing medical care.
- Open Access
- 22 June 2024
- Published by Sechenov University in National Health Care (Russia)
- Vol. 5 (1) , 50-57
Comprehensive rehabilitation model of children in need of upper limb prosthetics due to congenital diseases
Rehabilitation in the prosthetics process can significantly enhance patients’ functional abilities and their skill in managing prostheses. Nevertheless, most international rehabilitation recommendations for prosthetic users are aimed at adults. Prior to this research, Russian scientific studies had not proposed a comprehensive model that would integrate current scientific knowledge on the rehabilitation of children needing upper limb prosthetics due to congenital diseases.The aim of the study to develop an organizational-functional model of phased interdisciplinary medical rehabilitation for children requiring upper limb prosthetics due to congenital diseases.Materials and methods. Organizational-functional modeling based on the analysis of regulatory legal acts, scientific research, and guidelines for the medical rehabilitation of children with upper limb peculiarities.Results. The organizational-functional model of rehabilitation includes 3 stages: preparation for prosthetics, rehabilitation upon receiving the prosthetics, and family support during the use of the prosthetics. The main goals of each stage are developed, specialists responsible for solving specific tasks at each stage are identified, and organizations (divisions) responsible for the implementation of each stage are determined. Methodological materials for the parents of children from the target group have been created. Materials aim at optimizing interaction with families and their psychological support. A scheme for remote family support throughout the entire period of prosthetic use has been developed.Conclusion. The developed organizational-functional model of phased interdisciplinary medical rehabilitation for children needing upper limb prosthetics due to congenital diseases is designed to ensure adherence to the fundamental principles of rehabilitation – early start, phased approach, continuity, interdisciplinarity, individualized approach, as well as active family involvement in the rehabilitation process.
- 22 June 2024
- Published by Sechenov University in National Health Care (Russia)
- Vol. 5 (1) , 50-57
Open AccessComprehensive rehabilitation model of children in need of upper limb prosthetics due to congenital diseases
Rehabilitation in the prosthetics process can significantly enhance patients’ functional abilities and their skill in managing prostheses. Nevertheless, most international rehabilitation recommendations for prosthetic users are aimed at adults. Prior to this research, Russian scientific studies had not proposed a comprehensive model that would integrate current scientific knowledge on the rehabilitation of children needing upper limb prosthetics due to congenital diseases.The aim of the study to develop an organizational-functional model of phased interdisciplinary medical rehabilitation for children requiring upper limb prosthetics due to congenital diseases.Materials and methods. Organizational-functional modeling based on the analysis of regulatory legal acts, scientific research, and guidelines for the medical rehabilitation of children with upper limb peculiarities.Results. The organizational-functional model of rehabilitation includes 3 stages: preparation for prosthetics, rehabilitation upon receiving the prosthetics, and family support during the use of the prosthetics. The main goals of each stage are developed, specialists responsible for solving specific tasks at each stage are identified, and organizations (divisions) responsible for the implementation of each stage are determined. Methodological materials for the parents of children from the target group have been created. Materials aim at optimizing interaction with families and their psychological support. A scheme for remote family support throughout the entire period of prosthetic use has been developed.Conclusion. The developed organizational-functional model of phased interdisciplinary medical rehabilitation for children needing upper limb prosthetics due to congenital diseases is designed to ensure adherence to the fundamental principles of rehabilitation – early start, phased approach, continuity, interdisciplinarity, individualized approach, as well as active family involvement in the rehabilitation process.
- 23 April 2024
- Published by Media Sphere Publishing Group in Medical Technologies. Assessment and Choice
- Vol. 46 (4)
Pharmacogenetic testing for personalized statin prescription in Moscow
Objective. To study the features of pharmacogenetic testing for personalized statin prescription in Moscow. Material and methods. We analyzed data on medical genetics or pharmacogenetics or availability of equipment necessary for pharmacogenetic testing and personalized statin prescription posted on the websites of 19 hospitals. We clarified the possibility of pharmacogenetic testing through interviewing of laboratory employees by phone and assessed this process according to 6 criteria: biomaterial, molecular genetic methods, analyzed genes and genetic variants, period for completion, availability of consultation after testing and cost. Compliance of studied genes and genetic variants with the Clinical Pharmacogenetics Implementation Consortium (CPIC) recommendations was analyzed. The interviews were conducted twice in June-August 2022 and February—March 2023. Results. Upon survey, 5 hospitals were conducting pharmacogenetic testing, and 2 hospitals stopped these procedures due to unavailable reagents. Interview results were the same in both periods. There were significant differences in pharmacogenetic testing for most criteria. Period for completion varied from 5 days to 16 weeks, cost — from 4.1 thousand to 139 thousand rubles. The studied genes and genetic variants fully comply with the CPIC recommendations in none hospital. Conclusion. As of February-March 2023, pharmacogenetic testing for personalized statin prescription was performed in several Moscow hospitals, but there were significant differences in testing technologies, timing and cost. The studied genes and genetic variants did not fully comply with the CPIC recommendations that limits testing results for clinical decision-making.
- 23 April 2024
- Published by Media Sphere Publishing Group in Medical Technologies. Assessment and Choice
- Vol. 46 (4)
Pharmacogenetic testing for personalized statin prescription in Moscow
Objective. To study the features of pharmacogenetic testing for personalized statin prescription in Moscow. Material and methods. We analyzed data on medical genetics or pharmacogenetics or availability of equipment necessary for pharmacogenetic testing and personalized statin prescription posted on the websites of 19 hospitals. We clarified the possibility of pharmacogenetic testing through interviewing of laboratory employees by phone and assessed this process according to 6 criteria: biomaterial, molecular genetic methods, analyzed genes and genetic variants, period for completion, availability of consultation after testing and cost. Compliance of studied genes and genetic variants with the Clinical Pharmacogenetics Implementation Consortium (CPIC) recommendations was analyzed. The interviews were conducted twice in June-August 2022 and February—March 2023. Results. Upon survey, 5 hospitals were conducting pharmacogenetic testing, and 2 hospitals stopped these procedures due to unavailable reagents. Interview results were the same in both periods. There were significant differences in pharmacogenetic testing for most criteria. Period for completion varied from 5 days to 16 weeks, cost — from 4.1 thousand to 139 thousand rubles. The studied genes and genetic variants fully comply with the CPIC recommendations in none hospital. Conclusion. As of February-March 2023, pharmacogenetic testing for personalized statin prescription was performed in several Moscow hospitals, but there were significant differences in testing technologies, timing and cost. The studied genes and genetic variants did not fully comply with the CPIC recommendations that limits testing results for clinical decision-making.